Skip to content
Multiple Endocrine Neoplasia type 1 (MEN1) episode artwork

Feb 21, 2026 27 min

Multiple Endocrine Neoplasia type 1 (MEN1)

from OrphaChat — a Rare Disease Podcast Hosted by RCH

The provided sources explore the diagnosis, genetic basis, and multi-modal treatment of Multiple Endocrine Neoplasia type 1 (MEN1) and related conditions. Academic reviews and clinical guidelines highlight the role of the MEN1 gene in developing tumors within the parathyroid, pancreas, and pituitary glands, while emphasizing the importance of long-term surveillance. Medical research compares various surgical interventions, such as subtotal versus total parathyroidectomy, and discusses the efficacy of novel pharmacotherapies like somatostatin analogues and menin inhibitors. Additionally, several reports focus on the psychological impact of the syndrome, noting that genetic counselling and proximity to specialised care can significantly improve a patient's quality of life. Advanced functional imaging techniques, including PET/CT scans, are also identified as critical tools for early detection and managing neuroendocrine tumors. Together, these texts offer a comprehensive overview of the clinical challenges and emerging therapeutic advancements in hereditary endocrine disorders.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Multiple Endocrine Neoplasia type 1 (MEN1)

0:00 27:45

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of OrphaChat — a Rare Disease Podcast?

This episode is 27 minutes long.

When was this OrphaChat — a Rare Disease Podcast episode published?

This episode was published on February 21, 2026.

Can I download this OrphaChat — a Rare Disease Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.